<SEC-DOCUMENT>0001493152-21-004793.txt : 20210225
<SEC-HEADER>0001493152-21-004793.hdr.sgml : 20210225
<ACCEPTANCE-DATETIME>20210225090510
ACCESSION NUMBER:		0001493152-21-004793
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210219
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210225
DATE AS OF CHANGE:		20210225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sintx Technologies, Inc.
		CENTRAL INDEX KEY:			0001269026
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33624
		FILM NUMBER:		21676695

	BUSINESS ADDRESS:	
		STREET 1:		1885 WEST 2100 STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84119
		BUSINESS PHONE:		801-839-3516

	MAIL ADDRESS:	
		STREET 1:		1885 WEST 2100 STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84119

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMEDICA Corp
		DATE OF NAME CHANGE:	20121231

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMEDICA CORP
		DATE OF NAME CHANGE:	20031104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of Report (Date of earliest event reported): February 19, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SINTX
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-33624</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>84-1375299</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
        or other jurisdiction</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
        incorporation)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
        Number)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
        Employer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
        No.)</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1885
West 2100 South</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salt
Lake City, UT 84119</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices, including Zip Code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: <B>(801) 839-3500</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.5pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 36%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    Symbol(s):</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 40%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange on which registered:</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, par value $0.01 per share</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SINT</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    NASDAQ Capital Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;
230.405 of this chapter) or Rule 12b&ndash;2 of the Securities Exchange Act of 1934 (&sect; 240.12b&ndash;2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
1.01. Entry into a Material Definitive Agreement.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2021, SINTX Technologies, Inc. (the &ldquo;Company&rdquo;) announced that it had entered into a Patent License Agreement
(the &ldquo;Agreement&rdquo;) with O2 Design, Inc. (&ldquo;O2 Design&rdquo;), to commercialize face masks and mask filters that
incorporate the Company&rsquo;s sintered silicon nitride intended to inactivate the SARS-CoV-2 virus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the Agreement, the Company granted O2 Design an exclusive world-wide license under certain of the Company&rsquo;s
patents to make, use, and sell face masks and mask filters incorporating the Company&rsquo;s proprietary silicon nitride materials
for the purpose of enhancing the anti-viral properties of the face masks and mask filters, in partial consideration of an upfront
fee by O2 Design, royalties on the sale of face masks and mask filters incorporating silicon nitride materials and potential performance-based
milestone payments. There can be no assurances that a mask will be developed or that any of these milestones will be met. The
date by when the payment schedules for the upfront fees and royalties will go into effect shall be the same date as when a face
mask incorporating silicon nitride becomes available to sell. The Agreement also contains certain commercial diligence milestones
with respect to timing for development of the face mask and minimum net sales to be met in order to retain the exclusive license
to the Company patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will be the exclusive supplier of silicon nitride to O2 Design. The Company has agreed to supply to O2 Design its commercially
reasonable requirements of the Company&rsquo;s sintered silicon nitride powder (the &ldquo;Material&rdquo;). The Company has agreed
to exercise commercially reasonable efforts to manufacture the Material more efficiently and to pass on any savings to O2 Design.
The parties agreed to enter into a commercially standard supply agreement (&ldquo;Supply Agreement&rdquo;) within 30 days of execution
of the Agreement. The Supply Agreement will address, among other things, reasonable forecasting requirements and commitments,
requirements, and specifications relating to the delivery of the Material, shipping requirements, product acceptance, rejection
and returns, recalls, quality control and assurance, regulatory matters, returns, liability, indemnification, and other topics
addressed in industry standard supply agreements for comparable types of products to be used in the medical industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O2
Design has agreed to indemnify the Company, and hold harmless and defend the Company and its officers, directors, trustees, employees
and agents against any and all claims, suits, losses, damages, costs, liabilities, fees and expenses based on, resulting
from or arising out of: (i) the exercise of any license granted under the Agreement; and, (ii) any act, error or omission of O2
Design, or its officers, directors, employees or agents, including any breach of the Agreement, any claim or negligent acts or
omissions or misconduct, and product liability claim to the extent any such claims result from grossly negligent acts or omissions
or willful misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
earlier terminated, the Agreement will expire on February 18, 2023. The Company may terminate the Agreement if O2 Design should:
(a) fail to deliver to the Company any statement or report required when due; (b) fail to make any payment at the time that the
same should be due; (c) violate or fail to perform any material covenant, condition, or undertaking of the Agreement to be performed
by it; (d) cease use of commercially diligent efforts to commercialize a product; (e) file a bankruptcy action, or have
a bankruptcy action against it, or become insolvent; or (f) enter into a composition with creditors, or have a receiver appointed
for it. The Company may give written notice of such default to O2 Design. If O2 Design should fail to cure such default within
ninety (90) days of such notice, the rights, privileges, and license granted under the Agreement will automatically terminate.
Additionally, if O2 Design ceases to carry on its business with respect to the rights granted in the Agreement, the Agreement
will terminate upon thirty (30) days written notice by the Company. No termination of this Agreement by the Company will relieve
O2 Design of its obligation to pay any monetary obligation due or owing at the time of such termination and shall not impair any
accrued right of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O2
Design may terminate this Agreement, in whole or as to any specified patent, at any time and from time to time without cause,
by giving written notice thereof to the Company. Such termination shall be effective one hundred twenty (120) days after such
notice and all O2 Design&rsquo;s rights associated therewith shall cease as of that date. Any termination by O2 Design will not
relieve O2 Design of any obligation or liability accrued hereunder prior to such termination or rescind or give rise to any right
to rescind any payments made or other consideration given to the Company prior to the time such termination becomes effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
expiration or termination of the Agreement by either party, O2 Design will provide Company with a written inventory of all product
in process of manufacture, in use or in stock. O2 Design may dispose of any such product within the ninety (90) day period following
such expiration or termination, provided, however, that O2 Design will pay royalties and render reports to Company in the manner
specified in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of certain terms of the Agreement does not purport to be complete and is qualified in its entirety by reference
to the Agreement that the Company intends to file as an exhibit to its Quarterly Report on Form 10-Q for the period ended March
30, 2021, or other report that the Company may file with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;). The Company
intends to claim confidential treatment for certain portions of the Agreement pursuant to Item 601(b)(10) of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
7.01 Regulation FD Disclosure.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2021, the Company issued a press release with respect to entering into a patent license agreement with O2 Design,
Inc. A copy of this press release is filed herewith as Exhibit 99.1 and is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
information is intended to be furnished under Item 7.01 of Form 8-K and shall not be deemed &ldquo;filed&rdquo; for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), or incorporated by reference in
any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9.01 Financial Statements and Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.75in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex99-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of SINTX Technologies, Inc. dated February 25, 2021.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SINTX
    Technologies, Inc.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    25, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    B. Sonny Bal</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
    Sonny Bal</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
99.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O2TODAY
and SINTX Technologies Enter Commercialization Agreement to Fight COVID-19</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 234px; width: 393px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(Caption:
O2TODAY and SINTX executives signed an agreement to commercialize a &ldquo;catch-and-kill&rdquo; mask that will inactivate COVID-19
and other respiratory viruses.) </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SALT
LAKE CITY, UT, February 25, 2021 (GLOBE NEWSWIRE) &ndash; O2TODAY (&ldquo;O2TODAY&rdquo;), a mask company that develops, manufactures
and commercializes face masks for medical and non-medical uses, and SINTX Technologies, Inc. (NASDAQ: SINT) (&ldquo;SINTX&rdquo;
or the &ldquo;Company&rdquo;) (<U>www.sintx.com</U>), an original equipment manufacturer (OEM) of silicon nitride ceramics, announced
today they have entered into a worldwide exclusive licensing agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O2TODAY
expects to release their first consumer mask integrated with SINTX&rsquo;s silicon nitride during 2021. The mask will inactivate
pathogens in the fabric itself, therefore reducing the spread of viral diseases and effectively fighting against COVID-19. Since
the outbreak of COVID-19, SINTX Technologies has been testing the antiviral properties of silicon nitride for use in antipathogenic
applications. Rigorous safety, efficacy, and wearability tests are currently underway.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O2TODAY
and SINTX entered a collaboration during 2020 shortly after the COVID-19 pandemic was underway. The newly announced and signed
Technology License Agreement is a 2-year engagement, with an option for extension. The agreement includes a license fee, a commercial
agreement on silicon nitride sales, and royalties based upon product sales of the masks and filters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
are thrilled to enter this agreement with SINTX Technologies, a company that has a remarkable history of conducting the science
and developing products based on silicon nitride and its various formulations,&rdquo; said Bruce Lorange, CEO of O2TODAY. &ldquo;We
are passionate about respiratory health, and have been an innovator in the design, and manufacturing of protective face wear that
reduces exposure to airborne threats since 2015. We believe that this agreement will position O2TODAY as a market leader in the
next generation of face masks to combat COVID-19 and other air-borne ailments caused by viruses and bacteria.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;The
development of a catch-and-kill mask containing SINTX&rsquo;s silicon nitride is an important step towards offering viral protection
to healthcare professionals and the general public,&rdquo; said Dr. Sonny Bal, CEO and President of SINTX Technologies. &ldquo;Given
the effectiveness of silicon nitride in inactivating pathogens, there is an opportunity to turn what has been single-use masks
into a reusable PPE, thereby extending their life for healthcare workers and essential personnel.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O2TODAY
products are distributed through airport and travel retailers, direct-to-consumer, enterprise, and healthcare channels. COVID-19
has boosted the market demand for respiratory and surgical masks with overall shipments estimated to reach over 10 billion units
by 2025. Beyond COVID-19, there is a global need for respiratory hygiene, and the global reusable mask market is expected to continue
growing. In addition to disease-causing viruses and bacteria, particulate pollution, dust, and smoke, and respiratory diseases
are a reality in many countries, including the U.S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
control the supply chain from raw material to finished goods, and to meet the global demand for face masks driven by COVID-19,
O2TODAY established a new production facility in Salt Lake City, close to SINTX&rsquo;s manufacturing plant. O2TODAY produces
a range of products including surgical and N95 health care respirator masks, as well as replacement filters for its line of reusable
face masks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
O2TODAY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O2TODAY
(<U>www.O2TODAY.com</U>) is a privately-held company with its headquarters located in Salt Lake City, Utah. Even before the COVID-19
pandemic, O2TODAY designed and manufactured its proprietary face mask technology that helps reduce exposure to health threats
resulting from respiratory droplets, pathogens, allergens, dust, wildfire haze, and other forms of PM 2.5 particulate pollution.
As a member of 1% For The Planet, O2TODAY supports organizations driving initiatives to combat air pollution, the leading environmental
health threat on the planet, and promoting public health through education of the medical risks resulting from harmful air quality.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information on O2TODAY or its products, please visit <U>www.O2TODAY.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
SINTX Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SINTX
Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications.
The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external
partners. The Company presently manufactures silicon nitride powders and components in its FDA registered and ISO 13485:2016 certified
manufacturing facility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information on SINTX Technologies or its silicon nitride material platform, please visit www.sintx.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SINTX
Technologies: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform
Act of 1995 (PSLRA) that are subject to a number of risks and uncertainties. Risks and uncertainties that may cause such differences
include, among other things, SINTX&rsquo;s ability to complete its obligations under the agreement; the collaboration with O2TODAY
may not result in the development of any products; that SINTX has not as yet developed any products with antiviral properties
which incorporate the use of silicon nitride; products developed under the joint development agreement may not be effective against
the SARS-CoV-2 virus; incorporation of silicon nitride into personal protective equipment may not be safe or effective; volatility
in the price of SINTX&rsquo;s common stock; the uncertainties inherent in new product development, including the cost and time
required to commercialize such product(s); market acceptance of our products once commercialized; SINTX&rsquo;s ability to raise
additional funding and other competitive developments. Readers are cautioned not to place undue reliance on the forward-looking
statements, which speak only as of the date on which they are made and reflect management&rsquo;s current estimates, projections,
expectations and beliefs. There can be no assurance that any of the anticipated results will occur on a timely basis or at all
due to certain risks and uncertainties, a discussion of which can be found in SINTX&rsquo;s Risk Factors disclosure in its Annual
Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 26, 2020, and in SINTX&rsquo;s other filings
with the SEC. SINTX disclaims any obligation to update any forward-looking statements. SINTX undertakes no obligation to publicly
revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
Inquiries for SINTX:</B><BR>
SINTX Technologies<BR>
801.839.3502<BR>
<U>IR@sintx.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Inquiries for SINTX:</B><BR>
Amanda Barry<BR>
Associate Director, Content and PR<BR>
The Summit Group<BR>
<BR>
<U>abarry@summitslc.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #231F20"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
Inquiries for O2TODAY:</B><BR>
O2TODAY<BR>
<U>info@o2today.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #2E2E2E"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #2E2E2E"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" #J 8D# 2(  A$! Q$!_\0
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M\,_LT(.6.![5;0#<<]%XITH*XRQ//3-,0_)[FMZ6QG/<<[Y]@*C7]Y(!39'
MX!R:EMEQ%)+Z# ^M:;LG86XE$%A<S9P6&Q:K>#[???37!Z(NT'W-1Z]+Y-M#
M;]"1N-;7AJU^RZ2C,/GE.\_TK"O*RL:4EU-O-&:9FC-<;.D7=53S76ZN%!(
M3(XJR:.#UH3&+9RF2UC=CDD<FK(-5X@$4*HP!VJ4&D(G#5(&JN#4@-,"8-2A
MJB!IP:@1+FN1UEO-O;J0<@$(/PKIYIA#"\AZ*I-<D\HD(5OXLL:Z<.M6S&KM
M8DBF'E =A^M5[@'>3CDU)Y;)S'\X]/2JL[EQ@@@CKFNU.YSVL,;#*<GBLFZ@
MD#>8H) _.M9=N .M/(#=ATI2C<<68\,V1BIV^9?>DGT]XB7AY'4BHH9"S!>]
M3?N58]W\!WIO?!-J78 1*8FS[5XKK0":O<JIW*)&P?QKUWX:QE/!\3-T>1V
M_&O*O%L)M_$U\A&,R$_G4+J4S"<AI I.*GM99K6=)H&*NAR#59AF0;N15B,
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MUVN-1ZR1QWIK2+.?\HXY/YTTHPZBNA;1+J3 C2-F)P IZ^^:SA!&\QA64,S
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M=W.!Z4GB==2O[U]0FAS ,1J5.<>V*D\+VGV72$)8,TOSG':MAF?  /"G(!Y
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M(BN&MW(\K'T-8&H6^DI)FQNRKD\I&"R'_"D\+R233*5=SBTT:"WMG;VQ@;S
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MUJO#%N_U:?\ ?(J(P19_U2?]\BM8WM8+F67'09Q43*&;( 4>M;1@BV_ZI/\
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M-=/';P[/]5'_ -\BJXMH,G]S'_WR*TG'1"C(YQESFFX"]>372BV@_P">,?\
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:*/\ HL'3_GF*Z3[);_\ /"+_ +X%4D)L_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
